ReviewJournal of the American Association for Laboratory Animal Science : JAALAS2025
A Review of Experimental Models of Feline Kidney Disease.
Review in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) is a leading cause of mortality in cats, yet no treatments currently exist to reverse or halt its progression. This lack of therapeutic options stems partly from a limited understanding of the disease pathogenesis and the complexities of its heterogeneous nature. Experimental models of kidney disease are crucial for advancing research and improving treatment outcomes. These models facilitate the identification of biomarkers, elucidate disease mechanisms, and enable the testing of potential therapies. Several feline-specific models, such as ischemia-reperfusion injury (IRI), remnant kidney (RK), and toxin-induced injury (TI), have been developed to study feline kidney disease. Each model has distinct advantages and limitations, making the careful selection of appropriate models critical for progressing research in feline nephrology. The IRI model mimics acute kidney injury that can progress to CKD, while the RK model induces CKD by partially removing kidney tissue, leading to glomerular hyperfiltration. The TI model, involving toxins like meloxicam, provides a simpler approach to studying kidney damage. Despite their utility, these models present challenges, including variability in outcomes, technical demands, and the need for refined methodologies. This review examines the strengths and weaknesses of these feline models and offers recommendations for researchers working to discover new biomarkers and develop effective treatments for CKD in cats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.